Physician profile
Ryan Whitaker
NPI 1194266304
$6,213.71
in general payments reported to CMS, 2019-2025
7 companies · $5,847 in 2025
The $5,847 reported for 2025 was more than what 95% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $149 · 2024: $217 · 2025: $5,847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $5,093 · Food and Beverage: $762 · Travel and Lodging: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $5,092.50 |
| Food and Beverage | $762.24 |
| Travel and Lodging | $358.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $5,591.81 | 2025 | |
| Reflexion Medical, INC. | $156.00 | 2024 | Reflexion Medical Radiotherapy System |
| Novocure INC. | $149.33 | 2023 | Optune |
| Kite Pharma, INC. | $146.82 | 2025 | Yescarta |
| Astrazeneca Pharmaceuticals LP | $108.57 | 2025 | |
| Siemens Medical Solutions USA, INC. | $61.18 | 2024 | Eclipse Treatment Planning System For External Beam Radiation Therapy, Varian Treatment |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Whitaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.